Following the announcement of a $4.1 billion acquisition by Patient Square Capital, Patterson Companies (PDCO, Financials) saw its shares soar more than 30% in premarket trading on Wednesday. Given cash values of $31.35 per share, owners should enjoy a clear premium over the firm's current trading price.
Leading distributor of dentistry and animal health goods Patterson Companies reported a clear agreement to be bought by Patient Square Capital, a private equity company with a focus on healthcare. With the sale, the firm is valued at around $4.1 billion and pays cash to each shareholder $31.35 per share.
Subject to regulatory clearances and shareholder assent, the agreement is scheduled to finalize in the fourth quarter of Patterson's fiscal 2025, according a company release.
Ademi LLP, a legal company focused on shareholder rights, has taken notice of the purchase and declared an inquiry on whether Patterson's board behaved in the best interest of public shareholders and obtained a fair price for the deal.
Patterson posted its fiscal second-quarter results on December 5 before the acquisition announcement. With net revenues of $1.67 billiona meager 1.3% rise from the same time previous yearthe business said A cybersecurity hack at Change Healthcare, a third-party vendor, affected profits, hence the firm changed its projection of fiscal 2025 earnings.
This article first appeared on GuruFocus.免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。